New England Compounding Center Network Infrastructure Profile

Confidence

1

Public role: Profile subject linked to reviewed BTW article evidence.
Information type: This record preserves New England Compounding Center's organization identity while leaving legal entity, network resources, service scope, leadership, and related public sources open for enrichment.

NECC made sterile compounding and split oversight a patient-safety accountability test
NECC made sterile compounding and split oversight a patient-safety accountability test identifies New England Compounding Center in relation to a named role, organisation, or operating context.
authorized human evidence

Last updated: 2026-08-27

Legal type:InstitutionNot yet assessed

1

NECC made sterile compounding and split oversight a patient-safety accountability test
The 2012 fungal meningitis outbreak linked to contaminated preservative-free methylprednisolone acetate from New England Compounding Center exposed a control problem larger than one dirty room. Sterility evidence, lot release, environmental monitoring, prescription boundaries, interstate distribution, complaint escalation, patient notification and regulator authority all had to work as one safety system. They did not. The durable accountability question is whether compounders, purchasers and public authorities can now prove that weak signals stop production and distribution before a hidden microbial hazard reaches patients.
Primary articlePublished 2026-07-17